Ci Investments Inc. Dexcom Inc Transaction History

Ci Investments Inc.

$26.3 Billion
Q3 2024

A detailed history of Ci Investments Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Ci Investments Inc. holds 117,861 shares of DXCM stock, worth $8.94 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

117,861

Previous 14,697 701.94%

Holding current value

$8.94 Million

Previous $1.67 Million 374.25%

% of portfolio

0.03%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $6.6 Million - $12 Million	103,164 Added 701.94%	117,861 $7.9 Million
Q2 2024 Aug 12, 2024	SELL	$110.31 - $140.45 $428,995 - $546,210	-3,889 Reduced 20.92%	14,697 $1.67 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $614,732 - $754,018	5,382 Added 40.76%	18,586 $2.58 Million
Q4 2023 Feb 12, 2024	SELL	$75.49 - $124.16 $65,525 - $107,770	-868 Reduced 6.17%	13,204 $1.64 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $11.3 Million - $18.1 Million	-130,984 Reduced 90.3%	14,072 $1.31 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $15.3 Million - $17.8 Million	135,866 Added 1478.41%	145,056 $18.6 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $275,600 - $325,738	2,650 Added 40.52%	9,190 $1.07 Million
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $24,389 - $35,206	-287 Reduced 4.2%	6,540 $741,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $38,404 - $47,372	503 Added 7.95%	6,827 $550,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $294,464 - $575,546	4,331 Added 217.31%	6,324 $471,000
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $18,910 - $26,170	-201 Reduced 9.16%	1,993 $1.02 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $10,649 - $13,351	82 Added 3.88%	2,194 $1.18 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $60,931 - $81,755	571 Added 37.05%	2,112 $1.16 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $51,509 - $68,643	-636 Reduced 29.21%	1,541 $658,000
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $53,756 - $66,405	634 Added 41.09%	2,177 $782,000
Q4 2020 Feb 09, 2021	SELL	$78.0 - $104.5 $89,856 - $120,384	-1,152 Reduced 42.75%	1,543 $570,000
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $14,708 - $17,394	154 Added 6.06%	2,695 $1.11 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $6,957 - $11,692	111 Added 4.57%	2,541 $1.03 Million
Q1 2020 Aug 07, 2020	SELL	$47.79 - $75.63 $97,252 - $153,907	-2,035 Reduced 45.58%	2,430 $654,000
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $161,970 - $253,393	4,423 Added 10530.95%	4,465 $977,000
Q3 2019 Nov 08, 2019	BUY	$35.53 - $43.8 $1,492 - $1,839	42 New	42 $6,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Dexcom Inc Transaction History